The FDA approved Replimune’s treatment for advanced melanoma, dealing the company and patient advocates a big win after a tumultuous saga.

How each outlet headlined it

• STAT News

  The FDA approved Replimune’s treatment for advanced melanoma, dealing the company and patient advocates a big win after a tumultuous saga.
• STAT

  News: FDA approves Replimune melanoma drug previously rejected twice www.statnews.com/2026/08/06/r...
• The Wall Street Journal right

  Replimune Group says FDA has approved its therapy for advanced skin cancer, ending a regulatory saga that spanned three submissions and two rejections and was a flashpoint in the tenure of the agency’s last commissioner. on.wsj.com/4wJPDUl
• Reuters

  US FDA approves Replimune's skin cancer drug after prior rejections reut.rs/4wMe97h